|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-7-9
|
|
pubmed:abstractText |
This study assessed the efficacy, safety, and tolerability of the serotonin-norepinephrine reuptake inhibitor desvenlafaxine and the selective serotonin reuptake inhibitor escitalopram for major depressive disorder (MDD) in postmenopausal women.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1530-0374
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
700-11
|
|
pubmed:meshHeading |
pubmed-meshheading:20539246-Adult,
pubmed-meshheading:20539246-Aged,
pubmed-meshheading:20539246-Blood Pressure,
pubmed-meshheading:20539246-Citalopram,
pubmed-meshheading:20539246-Cyclohexanols,
pubmed-meshheading:20539246-Depressive Disorder, Major,
pubmed-meshheading:20539246-Double-Blind Method,
pubmed-meshheading:20539246-Female,
pubmed-meshheading:20539246-Humans,
pubmed-meshheading:20539246-Liver Function Tests,
pubmed-meshheading:20539246-Middle Aged,
pubmed-meshheading:20539246-Neurotransmitter Uptake Inhibitors,
pubmed-meshheading:20539246-Postmenopause,
pubmed-meshheading:20539246-Serotonin Uptake Inhibitors,
pubmed-meshheading:20539246-Sleep,
pubmed-meshheading:20539246-Weight Gain
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.
|
|
pubmed:affiliation |
McMaster University, Hamilton, Ontario, Canada. csoares@mcmaster.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
